Ravgen is a pioneering medical company based in Columbia, MD, specializing in non-invasive prenatal testing. With a focus on developing safe and highly accurate methods, Ravgen offers prenatal genetic testing for single gene disorders, such as cystic fibrosis and sickle cell anemia, as well as prenatal paternity testing. Their core technology involves increasing the percentage of fetal DNA present in the mother's blood, allowing for early detection and diagnosis.
Founded by Dr. Ravinder Dhallan, a highly trained and experienced physician with a background in biomedical engineering and clinical research, Ravgen has gained recognition for its groundbreaking work in the field. Their research and patented tests have been published in esteemed medical journals, including The New England Journal of Medicine and The Lancet. Committed to providing innovative solutions, Ravgen continues to lead the way in non-invasive prenatal testing.
Generated from the website